INTRODUCTION
Cyclic neutropenia in both human beings and grey collie dogs is characterized by the strikingly periodic occurrence of profound neutropenia. It has been recently recognized that the canine disease involves periodic fluctuations in all the formed elements of the blood-neutrophils, monocytes, lymphocytes, eosinophils, reticulocytes, and platelets (1) . Periodic changes in monocyte levels (2-4) and platelet counts (5) have been noted in the human malady and the suggestion has been made that periodic hematopoiesis underlies this disease in both man and dog (6) . To investigate the extent of the hematologic abnormalities in human This work was presented in part at the Annual Meeting of the American Society of Hematology, Hollywood, Fla., 6 December 1972.
Received for publication 24 May 1973 and in revised form 23 July 1973. cyclic neutropenia and to define the mechanism of its production we have performed detailed studies of the peripheral blood counts and the formation and fate of blood cells in four patients. The present studies indicate that in man, as in the grey collie dog, cyclic fluctuations of all blood elements occur. Periodic marrow failure, perhaps at the pluripotential, or early committed, stem cell level, is causal.
METHODS
Patients. Two women, ages 67 and 23 yr (patients 1 and 3), with symptoms strongly suggestive of childhoodonset cyclic neutropenia and two boys, ages 9 and 8 yr (patients 2 and 4), with disease well documented from early childhood were the subjects of these studies. The patients were unrelated, and none had a family history of neutropenia. Except for periodic fevers, aphthous stomatitis, and occasional infections accompanying severe neutropenia (7) , the patients were in good health. None had splenomegaly by either physical examination or technetium (9Tc) scan. Patient 1 had a normal spleen removed before study without change in her disease.
Blood counts. Leukocyte, erythrocyte, and plateletcounts were made on EDTA-anticoagulated samples using an electronic particle counter' and standard techniques (8) (9) (10) . ing observations. The significance of the largest peak of the periodogram was determined by the Fisher statistic (g), which is the ratio of the height of this peak to the area between the periodogram and the horizontal axis (1, 13) . Data from a normal volunteer studied over 89 consecutive days were identically analyzed for comparison (12) .
Bone marrow. Aspirates of bone marrow were taken from the posterior iliac crest on 5 days of a single 21-day cycle in patient 1. In each of the other patients from one to three aspirates were obtained during the neutropenic and recovery phases of a cycle. Differential cell counts of at least 500 nucleated cells were made on Wright's stained smears.
Marrow neutrophil reserves. Marrow reserves were tested in each patient during the neutropenic and recovery phases of several cycles. Base-line (preinjection) and hourly neutrophil counts were done for 6 h after intravenous infusion of 0.8 ng/kg of Salmonella abortus equi endotoxin (Lipexal') and 200 mg of hydrocortisone sodium succinate (Solu-Cortef 5). Counts were also done before and 12, 15, and 18 h after intramuscular administration of 0.1 mg/kg of etiocholanolone. 6 The maximum increase in the blood neutrophil count over baseline was used as a measure of the marrow reserve. The mean neutrophil count for all patients during neutropenia was 97.6+33.0/mm3 and during recovery was Boyum (19, 20) . The leukocytes of the final cell preparation were regularly greater than 95% PMNs. Overall recovery of PMNs was usually 40-60%c.
After counting the cells with an electronic particle counter, they were digested with 0.2 N NaOH at 60°C
and acidified with 10% acetic acid. This material was solubilized in the above-mentioned toluene-phosphor system and radioactivity measured with a liquid scintillation counter.' The specific activity for each sample was expressed as counts per minute per cell. The slope and tj for the specific activity curves were calculated by the methods of least squares (21) . The total body, marginal, and circulating neutrophil pools and neutrophil turnover rates were measured by extrapolating the specific activity decay curves to time zero and applying the formulae of Cartwright, Athens, and Wintrobe (17) . All curves were of the "C" type described by Athens et al. (18) . The FIGuRE 4 Periodograms of serial blood counts in human cyclic neutropenia (patient 1) and a normal volunteer. Significant periodicity is seen only in the neutrophil, monocyte, lymphocyte, platelet, and reticulocyte counts of patient 1. lanolone (2,600 or more granulocytes/mm', [24] ) and/ or endotoxin (2,000 or granulocytes/mm' [25] ) were established in three patients (patients 1, 2, and 4). Although the neutrophil response to these two agents during the recovery phase was far greater than during neutropenia for patient 3, the patient with the most marked neutropenia, it did not approach the normal range. In all patients the neutrophil response to the acute administration of hydrocortisone roughly paralleled that of the other agents.
In (Fig. 7) showed the first peak to be made up primarily of labeled neutrophils and the second to be almost entirely devoid of these cells.
Serum muramidase. Frequent determinations of serum muramidase were done for at least one cycle in each patient. Fig. 8 Leukokinetic studies. In each patient a neutrophil blood half-time was obtained just before the development of neutropenia by following the disappearance of in vitro DF3'P-labeled autologous neutrophils (Table  I ). In the four patients studied on cycle days 15, 17, 18 , and 20, neutrophil ti was normal or slightly prolonged. The mean for our patients was 8.5 h, compared to 6.6 h in normals (26) . Blood granulocyte pool sizes-circulating, marginal, and total blood granulocyte poolswere generally small and probably reflect the degree of peripheral neutropenia.
DISCUSSION
These studies demonstrate that human cyclic neutropenia is remarkably periodic. The finding in the patient most thoroughly studied that neutrophils, monocytes, lymphocytes, platelets, and reticulocytes all cycle with strict periodicity suggests that this disease in man should be viewed as cyclic hematopoiesis, not merely as cyclic neutropenia. That the period length is approximately the same for each cell type and that each cell type follows an entirely separate pattern of fluctuation suggest that production of all marrow elements is simultaneously disturbed at one point in the cycle. If marrow production fails at an early precursor cell level between cycle days 12 and 16, at about the zenith of peripheral neutrophil recovery, and subsequently resumes, then successive peaks of each cell type should appear in the peripheral blood. The time and order of appearance of each cell type should reflect its marrow transit time. The invariable appearance of increasing numbers of reticulocytes at 4-5 days after 3226 D. Guerry, IV, D. C. Dale, M. Omine, S. Perry, and S. M. Wolff cycle day 16 and of neutrophils 9-11 days after this time (Fig. 3 ) is in keeping with what is known of the time required for these cells to transit the marrow proliferating and maturing pools (27, 28) . From our data, it would seem that the time required to generate a blood monocyte from early precursors is intermediate, 6-8 days, but little data in humans bear on this point. This time-course would appear to be a reasonable one since monocytes probably arise from the same committed stem cell as the neutro'hil (29, 30) , but do not reside in any marrow storage pool for an appreciable period of time (31) . In addition, the return of monocytes often precedes by a few days the return of granulocytes after periods of marrow suppression. The model of monocytopoiesis recently constructed by Meuret (31) giving a marrow to blood transit time of 56 h is considerably less than our data would indicate, but this time span represents an absolute minimum. Because the precise time of onset of marrow recovery cannot be pinpointed, a more exact transit time cannot be designated for each cell type. A platelet peak fixed in relationship to the other cell types is not apparent in our data, but in the dog the platelet is invariably the first element to increase (1) .
Unfortunately, similar detailed investigation of the other three patients could not be performed because of their unavailability for long-term study. Thus the data are not adequate to permit a categorical statement that all blood elements cycle, but that this obtains is strongly suggested by examination of many short-term observations in these patients and corroborated by the common observation of cyclic monocyte fluctuations (2-4) and the single report of periodic platelet oscillations (5) in human cyclic neutropenia. To convincingly demonstrate periodicity requires a long-term, equally spaced series of observations with few gaps. Such data must be examined by statistical methods as well as visual inspection (12) , a goal often difficult to achieve with patients.
The balance of the data collected in this group of patients relates directly to the marrow myeloid events determining the peripheral blood cycle. Marrow morphological studies in our patients are in agreement with those of others (2, 32) PATIENT FIGURE 6 Bone marrow neutrophil reserves to three agents during neutropenia and recovery in four patients with human cyclic neutropenia. Endotoxin was not used in patient 2 during the recovery phase.
Serum muramidase levels rise during midneutropenia and peak just before the recovery of the peripheral neutrophil count and would seem to reflect marrow granulocytopoietic activity (33) . That this enzyme parallels the monocyte count may indicate an important contribution by these cells to the serum enzyme levels.
These morphological and functional data indicate that fluctuation in blood neutrophils is secondary to fluctuating rates of cell production. Marrow production is turned on during neutropenia and switched off after the peripheral blood neutrophil count is reconstituted. That neutrophil production is qualitatively normal during the late neutropenic period is demonstrated by the first in vivo [3H]TdR-labeling study. In a similar investigation Meuret and Fliedner (32) have shown, by labeling slightly later in the cycle, a shortened com- (36) .
The normal muramidase levels at the onset of neutropenia are also supportive of the concept that peripheral neutrophil destruction (33) is not involved in this disease. The muramidase fluctuations probably reflect the periodic increase in both monocyte and neutrophil production. Our data in human cyclic neutropenia are remarkably analogous to that obtained in detailed studies of the hematopoietic system in the grey collie dog (1, 6) . Periodic oscillations in the levels of each of the peripheral blood cell types, in marrow morphology, marrow reserve responses, and muramidase levels characterize both the human and canine diseases. Normal blood granulocyte survival is also found in both. While the period length of the cycle in the dog is shorter than in man, 12 days as opposed to 21, this difference is determined by the shorter marrow to blood transit time (37, 38) . The heritable nature of the disease and the associated pigmentary changes in the dog (39) are not apparent in affected human beings.
While (42, 43) or long-range humoral stimulators or inhibitors. Cyclic increases in urinary colony-stimulating activity, a possible granulopoietin (29) , during late neutropenia and the early recovery phase in both grey collie dogs (44) and man,2' and concomitant cycling of erythropoietin (45) in the canine disease indicate that disturbance of these regulators may be of possible pathogenetic importance. On the other hand, the recent demonstration that normal, noncyclic hematopoiesis can be restored in the grey collie by allogeneic bone marrow transplantation from a normal collie is evidence in favor of a defect of early precursor cells (46) . The close congruity of the human and dog disease should allow, through manipulation of the canine model, the generation of important data on the regulation of both normal and abnormal hematopoiesis in both speices.
